ApprovalTrail

Approval · Notice of Compliance 12635 · 2011

RUBY-FILL: Notice of Compliance 12635

Issued September 20, 2011

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
12635
Date
September 20, 2011
Company
Jubilant Draximage Inc.Kirkland, Quebec, Canada
Product type
Radiopharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Priority-NAS
Therapeutic class
Diagnostic Radiopharmaceutical

Products in this notice

BrandDINStatus today
RUBY-FILLNot yet assigned—

Medicinal ingredients